These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 12866712

  • 1. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
    Pałucha A, Pilc A.
    Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
    [Abstract] [Full Text] [Related]

  • 2. The involvement of glutamate in the pathophysiology of depression.
    Palucha A, Pilc A.
    Drug News Perspect; 2005 May; 18(4):262-8. PubMed ID: 16034483
    [Abstract] [Full Text] [Related]

  • 3. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A, Pilc A.
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [Abstract] [Full Text] [Related]

  • 4. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
    Chaki S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):219-26. PubMed ID: 23012890
    [Abstract] [Full Text] [Related]

  • 5. Mood disorders: regulation by metabotropic glutamate receptors.
    Pilc A, Chaki S, Nowak G, Witkin JM.
    Biochem Pharmacol; 2008 Mar 01; 75(5):997-1006. PubMed ID: 18164691
    [Abstract] [Full Text] [Related]

  • 6. Glutamate-based antidepressants: preclinical psychopharmacology.
    Pilc A, Wierońska JM, Skolnick P.
    Biol Psychiatry; 2013 Jun 15; 73(12):1125-32. PubMed ID: 23453290
    [Abstract] [Full Text] [Related]

  • 7. The role of glutamate on the action of antidepressants.
    Hashimoto K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug 15; 35(7):1558-68. PubMed ID: 20600468
    [Abstract] [Full Text] [Related]

  • 8. Do glutamatergic agents represent a new class of antidepressant drugs? Part 1.
    Sanacora G.
    J Clin Psychiatry; 2009 Oct 15; 70(10):1473-5. PubMed ID: 19906350
    [No Abstract] [Full Text] [Related]

  • 9. Role of metabotropic glutamate receptors in animal models of Parkinson's disease.
    Senkowska A, Ossowska K.
    Pol J Pharmacol; 2003 Oct 15; 55(6):935-50. PubMed ID: 14730087
    [Abstract] [Full Text] [Related]

  • 10. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.
    Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R.
    Pharmacopsychiatry; 1996 Jan 15; 29(1):23-6. PubMed ID: 8852530
    [Abstract] [Full Text] [Related]

  • 11. Emerging role of glutamate in the pathophysiology of major depressive disorder.
    Hashimoto K.
    Brain Res Rev; 2009 Oct 15; 61(2):105-23. PubMed ID: 19481572
    [Abstract] [Full Text] [Related]

  • 12. Does interaction between zinc and glutamate system play a significant role in the mechanism of antidepressant action?
    Nowak G.
    Acta Pol Pharm; 2001 Oct 15; 58(1):73-5. PubMed ID: 11370292
    [Abstract] [Full Text] [Related]

  • 13. Glutamate-based antidepressants: 20 years on.
    Skolnick P, Popik P, Trullas R.
    Trends Pharmacol Sci; 2009 Nov 15; 30(11):563-9. PubMed ID: 19837463
    [Abstract] [Full Text] [Related]

  • 14. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
    Stahl SM.
    J Clin Psychiatry; 1984 Oct 15; 45(10 Pt 2):37-45. PubMed ID: 6090439
    [Abstract] [Full Text] [Related]

  • 15. Roles of glutamate signaling in preclinical and/or mechanistic models of depression.
    Tokita K, Yamaji T, Hashimoto K.
    Pharmacol Biochem Behav; 2012 Feb 15; 100(4):688-704. PubMed ID: 21536063
    [Abstract] [Full Text] [Related]

  • 16. Metabotropic glutamate receptors in the control of mood disorders.
    Witkin JM, Marek GJ, Johnson BG, Schoepp DD.
    CNS Neurol Disord Drug Targets; 2007 Apr 15; 6(2):87-100. PubMed ID: 17430147
    [Abstract] [Full Text] [Related]

  • 17. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.
    Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, Schreiber R.
    Behav Pharmacol; 2003 Jul 15; 14(4):257-77. PubMed ID: 12838033
    [Abstract] [Full Text] [Related]

  • 18. Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test.
    Pałucha-Poniewiera A, Pilc A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct 01; 39(1):102-6. PubMed ID: 22651960
    [Abstract] [Full Text] [Related]

  • 19. Are compounds acting at metabotropic glutamate receptors the answer to treating depression?
    Palucha A.
    Expert Opin Investig Drugs; 2006 Dec 01; 15(12):1545-53. PubMed ID: 17107280
    [Abstract] [Full Text] [Related]

  • 20. NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice.
    Pomierny-Chamioło L, Poleszak E, Pilc A, Nowak G.
    Pharmacol Rep; 2010 Dec 01; 62(6):1186-90. PubMed ID: 21273676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.